MedPath

Characterization of the Gut Microbiota Composition and Activity After Three Weeks of Chitin-glucan Supplementation

Not Applicable
Completed
Conditions
Healthy
Registration Number
NCT03505177
Lead Sponsor
Nathalie Delzenne
Brief Summary

The aim of this research study is to characterize gut microbiota composition and activity after a daily supplementation of 4.5 g of chitin-glucan during 3 weeks. For this purpose, a monocentric longitudinal intervention study without control will be performed. Fecal microbiota composition and fecal concentrations of gut microbiota-derived metabolites (bile acids, conjugated-polyunsaturated fatty acids and short-chain fatty acids) will be measured. In addition, during ten hours following the ingestion of a test meal rich in fibers, the kinetic of production of H2, methane and volatile compounds exhaled from breath will be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Woman or man, aged of 18 to 40 years
  • Body mass index (BMI) between 18 and 25 kg/m2
  • In good general health as evidenced by medical history and physical examination
  • Non-smoker
  • Caucasian
  • H2 - producer
  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
Exclusion Criteria
  • Subjects presenting gastro-intestinal disorders such as ulcers, diverticulitis and inflammatory bowel diseases
  • Subject presenting allergy or food intolerance (lactose, gluten,...)
  • Subjects with psychiatric problems and/or using antipsychotics
  • Current or recent (< 4 weeks) intake of antibiotic, probiotic, prebiotic, fiber supplement, and/or any product modulating gut transit
  • Feeding particular diet such as vegetarian diet or hyper protein diet
  • Chronic intake of drug, excepted contraceptive drug
  • Pregnant or lactating woman or woman who did not use highly effective contraception
  • Subjects who drink more than 3 glasses of alcohol per day (> 30 g of alcohol per day)
  • Subjects having participated to another clinical trial two weeks before the screening test visit
  • Subjects presenting an allergy or intolerance to one component of the product tested

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Gut microbiota compositionDifference between day 0 and day 21

Illumina sequencing of 16SrDNA

Secondary Outcome Measures
NameTimeMethod
Fecal short-chain fatty acidsDifference between day 0 and day 21

Gas chromatography using Flame ionization detector (GC- FID)

Fecal bile acidsDifference between day 0 and day 21

Gas chromatography-mass spectrometry (GC/MS)

Exhaled acetateDifference between day 0 and day 21

Gas chromatography using Flame ionization detector (GC- FID) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Fecal conjugated-linoleic acidsDifference between day 0 and day 21

Gas chromatography using Flame ionization detector (GC- FID)

Exhaled propionateDifference between day 0 and day 21

Gas chromatography using Flame ionization detector (GC- FID) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled H2SDifference between day 0 and day 21

Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled CH4Difference between day 0 and day 21

Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled H2Difference between day 0 and day 21

Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Gastro-intestinal symptom - nauseaDifference between Day 0 and Day 21

100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled butyrateDifference between day 0 and day 21

Gas chromatography using Flame ionization detector (GC- FID) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled C2Difference between day 0 and day 21

Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled CO2Difference between day 0 and day 21

Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled O2Difference between day 0 and day 21

Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled CODifference between day 0 and day 21

Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Gastro-intestinal symptom - flatulencesDifference between Day 0 and Day 21

100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Gastro-intestinal symptom - gastrointestinal refluxDifference between Day 0 and Day 21

100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled N2Difference between day 0 and day 21

Gas chromatography using Thermal Conductivity Detector (GC-TCD) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Exhaled volatile compoundsDifference between day 0 and day 21

Gas chromatography using selected ion flow tube mass spectrometry - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Gastro-intestinal symptom - discomfortDifference between Day 0 and Day 21

100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Gastro-intestinal symptom - crampsDifference between Day 0 and Day 21

100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Gastro-intestinal symptom - rumblingDifference between Day 0 and Day 21

100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Gastro-intestinal symptom - burpsDifference between Day 0 and Day 21

100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Gastro-intestinal symptom - bloatingDifference between Day 0 and Day 21

100 mm Visual analog scale (0 = no symptom, 100 = very severe symptom) - Area under the curve (calculated on 10 hours following high-fiber test meal ingestion)

Trial Locations

Locations (1)

Center of Investigation in Clinical Nutrition

🇧🇪

Louvain-la-Neuve, Belgium

Center of Investigation in Clinical Nutrition
🇧🇪Louvain-la-Neuve, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.